Sugi Predict

Sugi Predict / Compounds / SCHEMBL3496746

SCHEMBL3496746

SCHEMBL3496746

COCCN1C(=O)C(C)(C)Oc2cc(Nc3ncc(-c4cccc(C(N)=O)c4)c(NC4CC(C)(C)NC(C)(C)C4)n3)cnc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 5/20 0.38
▸ PLK4 O00444 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ STK16 O75716 1/20 0.35
▸ LATS1 O95835 1/20 0.35
▸ RET P07949 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ MST1R Q04912 1/20 0.35
▸ PTK2 Q05397 1/20 0.35
▸ TNK1 Q13470 1/20 0.35
▸ IKBKE Q14164 1/20 0.35
▸ MAP3K11 Q16584 1/20 0.35
▸ BRDT Q58F21 1/20 0.35
▸ ADCK1 Q86TW2 1/20 0.35
▸ PIP4K2C Q8TBX8 1/20 0.35
▸ NEK9 Q8TD19 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ ABCG2 Q9UNQ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3497069 0.93 SYK (0.38) SYKPLK4AURKASTK16LATS1
SCHEMBL3495108 0.93 IRAK4 (0.37) SYKPLK4AURKASTK16LATS1
SCHEMBL3497189 0.90 SYK (0.39) SYKJAK3JAK2JAK1MAP3K7
SCHEMBL3495507 0.88 CYP1A2 (0.43) SYKPLK4AURKASTK16LATS1
SCHEMBL3494877 0.84 SYK (0.43) SYKFLT3MAP3K7IRAK4TYRO3
SCHEMBL3495365 0.83 SYK (0.39) SYKRETJAK3JAK2JAK1
SCHEMBL3495095 0.82 CYP1A2 (0.38) SYKPLK4AURKASTK16LATS1
SCHEMBL3495247 0.81 CYP1A2 (0.44) SYKMAP3K7IRAK4KDRUSP2
SCHEMBL3495597 0.81 IRAK4 (0.37) SYKJAK3JAK1MAP3K7IRAK4
SCHEMBL3496742 0.81 SYK (0.44) SYKJAK3JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. 2010-05-27 — — US claimed
EP-2183225-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2010-05-12 — — EP claimed
WO-2009012421-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2009-01-22 — — WO claimed
US-8993585-B2 Cyclic amine substituted pyrimidinediamines as PKC inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2015-03-31 — — US disclosed
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. 2010-05-27 — — US disclosed
EP-2183225-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2010-05-12 — — EP disclosed
WO-2009012421-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2009-01-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130486-A1 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS PRKCH, PKD2, PRKCQ SYK 460/4885PLK4 532/4885AURKA 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.